Lepu Pharmaceutical
Lepu Pharmaceutical, also known as Lepu Medical Technology (Beijing) Co., Ltd., is a prominent player in the healthcare industry, headquartered in Beijing, China. Founded in 1999, the company has established itself as a leader in the development and manufacturing of innovative medical devices, particularly in the fields of cardiovascular intervention, diagnostic imaging, and in vitro diagnostics. With a strong presence in both domestic and international markets, Lepu Pharmaceutical has achieved significant milestones, including numerous product certifications and partnerships that enhance its global reach. The company’s core offerings, such as stents, catheters, and diagnostic kits, are distinguished by their advanced technology and commitment to quality, positioning Lepu as a trusted name in healthcare solutions. Recognised for its contributions to medical advancements, Lepu continues to drive innovation and improve patient outcomes worldwide.
DitchCarbon Score
How does Lepu Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Lepu Pharmaceutical's score of 1 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Lepu Pharmaceutical's reported carbon emissions
Lepu Pharmaceutical, headquartered in China (CN), currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of concrete emissions data, it is important to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate commitments. This often includes setting science-based targets for emissions reductions and engaging in initiatives aimed at minimising their carbon footprint. However, without specific information from Lepu Pharmaceutical, it is unclear what specific actions or commitments they may have undertaken in this regard.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Lepu Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
